Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy

Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy

<b>Background</b>: Non-infectious uveitis represents a leading cause of visual impairment, and inflammation control represents a major priority in tackling visual acuity loss due to complications such as macular edema; different immunomodulatory drugs are currently being used, including...

Full description

Bibliographic Details
Main Authors: Vittorio Pirani, Paolo Pelliccioni, Serena De Turris, Alessandro Rosati, Alessandro Franceschi, Pierangelo Pasanisi, Rosaria Gesuita, Michele Nicolai, Cesare Mariotti
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Clinical Medicine
Subjects:
adalimumab
anti-tnf-α
non-infectious uveitis
refractory uveitis
inflammatory macular edema
macular thickness
choroidal thickness
retinal vasculitis
retinal hyperreflective spots
Online Access:https://www.mdpi.com/2077-0383/9/2/510

Internet

https://www.mdpi.com/2077-0383/9/2/510

Similar Items